Clinical Trials Browser

Phase 2 × Has results × Interleukin-15 × Clear all

NCT04150562 2022-05-17

Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma

Phase 2 Terminated

2 enrolled 13 charts

Carcinoma, Renal Cell

NCT02395822 2018-02-20

MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients

Phase 2 Completed

17 enrolled 13 charts

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute